Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Blinding01:11

Blinding

4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Sample Size Calculation01:19

Sample Size Calculation

6.9K
Knowledge of the sample size is the first requirement to conduct random sampling or an experiment. The sample size is the total number of units, observations, or groups (in some cases) used to get the data to estimate a population parameter. As the name suggests, the sample size is that of the sample drawn from the population and differs from the population size.
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
6.9K
Blind Procedures02:07

Blind Procedures

13.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.8K
Bonferroni Test01:10

Bonferroni Test

3.5K
The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
3.5K
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

4.0K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mycophenolate dosing in childhood nephrotic syndrome - Authors' reply.

The Lancet. Child & adolescent health·2026
Same author

Inclusive Language for Inclusive Care-A Proposal for an LGBTQI<sup>+</sup> Glossary for European Neurologists.

European journal of neurology·2026
Same author

Lumbar drainage in intracerebral haemorrhage with intraventricular haemorrhage (DRAIN IVH): protocol for a multi-centre, randomised-controlled, two-arm, assessor-blinded trial.

European stroke journal·2026
Same author

Estimation, testing and sample size calculation within the responder-stratified exponential survival model.

Journal of biopharmaceutical statistics·2026
Same author

Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial.

The Lancet. Child & adolescent health·2026
Same author

Parental mental illness and child brain structure: A diffusion MRI study of emotion regulation related pathways.

NeuroImage·2026
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Blinded sample size recalculation in clinical trials with binary composite endpoints.

Anja Sander1, Geraldine Rauch1, Meinhard Kieser1

  • 1a Institute of Medical Biometry and Informatics , University of Heidelberg , Heidelberg , Germany.

Journal of Biopharmaceutical Statistics
|June 14, 2016
PubMed
Summary
This summary is machine-generated.

This study introduces an internal pilot study design for clinical trials with composite endpoints. This approach helps adjust sample size based on interim estimates, improving the chances of achieving desired statistical power.

Keywords:
Clinical trialscomposite endpointsinternal pilot study designmultiple testingsample size recalculation

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Related Experiment Videos

Last Updated: Mar 19, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • Pharmaceutical Research

Background:

  • Clinical trials with binary composite endpoints face challenges in sample size planning.
  • Accurate estimation of event rates and test statistic correlation is difficult, risking underpowered trials.
  • Fixed sample size designs may fail to achieve intended power due to uncertain nuisance parameters.

Purpose of the Study:

  • To propose an internal pilot study design for clinical trials with composite endpoints.
  • To address the challenges in sample size planning by estimating nuisance parameters at an interim stage.
  • To revise sample size based on blinded interim estimates to maintain statistical power.

Main Methods:

  • Implementation of an internal pilot study with blinded estimation of nuisance parameters.
  • Sample size re-estimation at an interim analysis point.
  • Investigation of the proposed design's characteristics: Type I error rate, power, and sample size.

Main Results:

  • The proposed internal pilot study design maintains the actual Type I error rate.
  • It demonstrates improved power compared to fixed sample size designs when nuisance parameters are uncertain.
  • The design provides a mechanism for sample size adjustment, leading to more efficient trials.

Conclusions:

  • The internal pilot study design is a valuable tool for clinical trials with composite endpoints.
  • It effectively manages uncertainty in nuisance parameters, enhancing the reliability of trial outcomes.
  • This approach offers a practical solution for optimizing sample size and power in complex trial designs.